AR016071A1 - Antagonistas de endotelina, composiciones farmaceuticas y uso de dichos compuestos para preparar medicamentos - Google Patents

Antagonistas de endotelina, composiciones farmaceuticas y uso de dichos compuestos para preparar medicamentos

Info

Publication number
AR016071A1
AR016071A1 ARP980102851A ARP980102851A AR016071A1 AR 016071 A1 AR016071 A1 AR 016071A1 AR P980102851 A ARP980102851 A AR P980102851A AR P980102851 A ARP980102851 A AR P980102851A AR 016071 A1 AR016071 A1 AR 016071A1
Authority
AR
Argentina
Prior art keywords
hydrogen
lower alkyl
alkylene
haloalkyl
alkenylene
Prior art date
Application number
ARP980102851A
Other languages
English (en)
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of AR016071A1 publication Critical patent/AR016071A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Un compuesto que comprende la formula (I), en donde: R es -(CH2)m-W, en donde m es un entero desde 0-6 y W es (a)-C(O)2-G, (b)-PO3H2,(c) -P(O)(OH)E,(d) -CN(e)-C(O)NHR17, alquilaminocarbonilo, dialquilaminocarbonilo, tetrazolilo, hidroxi, alcoxi, sulfonamido, -C(O)NHS(O)2R16, -S(O)2NHC(O)R16, o se selecciona entrelas formulas (n) a (u); G es hidrogeno o un grupo protector de carboxi; E es hidrogeno, alquilo inferior o arilalquilo; R17 es alquilo inferior; R16 es alquiloinferior, haloalquilo, arilo o dialquilamino; R1 y R2 son independientemente seleccionados de hidrogeno, alquilo inferior, alquenilo, alquinilo, alcoxialquilo,alcoxicarbonilalquilo, hidroxialquilo, haloalquilo, haloalcoxialquilo, alcoxialcoxialquilo, tioalcoxialcoxialquilo, cicloalquilo, cicloalquilalquilo,aminocarbonilalquilo, alquilaminocarbonilalquilo, dialquilaminocarbonilalquilo, aminocarbonilalquenilo, alquilaminocarbonilalquenilo, dialquilaminocarbonilalquenilo, hidroxialquenilo, arilo, arilalquilo, ariloxialquilo,arilalcoxialquilo, heterocíclico, alquilo(heterocíclico) y (Raa)(Rbb)N-Rcc-, en donde Raa esarilo o arilalquilo, Rbb es hidrogeno o alcanoílo, y Rcc es alquileno, con la condicion de que uno o ambos de R1 y R2 no es hidrogeno; R3 es R4-C(O)-R5, oR6-S(O)2-R7-, en donde R5 es un enlace covalente, alquileno, alquenileno, -N(R20)-R8- o -R8a-N(R20)-R8-, o -O-R9 o -R9a-O-R9-; en donde R8 y R8a sonindependientemente alquileno o alquenileno; R20 es hidrogeno, alquilo inferior, alquenilo, haloalquilo, alcoxialquilo, haloalcoxialquilo, cicloalquilo ocicloalquilalquilo; y R9 y R9a son independientemente alquileno; R7 es: un enlace covalente, alquileno, alquenileno o -N(R21)- R10 o -R10a-N(R21)-R10, en dondeR10 y R10a son independientemente seleccionados entre alquileno y alquenileno, y R21 es hidrogeno, alquilo inferior, alquenilo, haloalquilo, alcoxialquilo,haloalcoxialquilo, arilo o arilalquilo; R4 y R6 tienen la formula (II), en donde R11 y R12 son independientemente alquilo inferior, ciano,alcoxi, halo,haloalquilo o fenilo, y R13, R14 y R15 independientemente se seleccionan entre hidrogeno, alquilo inferior, hidroxi, amino, alcoxi, arilo, heterocíclico, halo,
ARP980102851A 1997-06-17 1998-06-16 Antagonistas de endotelina, composiciones farmaceuticas y uso de dichos compuestos para preparar medicamentos AR016071A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87718797A 1997-06-17 1997-06-17

Publications (1)

Publication Number Publication Date
AR016071A1 true AR016071A1 (es) 2001-06-20

Family

ID=25369437

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980102851A AR016071A1 (es) 1997-06-17 1998-06-16 Antagonistas de endotelina, composiciones farmaceuticas y uso de dichos compuestos para preparar medicamentos

Country Status (8)

Country Link
AR (1) AR016071A1 (es)
AU (1) AU7826398A (es)
BG (1) BG103986A (es)
HU (1) HUP0002681A3 (es)
NO (1) NO996244L (es)
PL (1) PL348667A1 (es)
WO (1) WO1998057933A1 (es)
ZA (1) ZA985209B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7291626B1 (en) 1998-04-09 2007-11-06 John Hopkins University School Of Medicine Inhibitors of hedgehog signaling pathways, compositions and uses related thereto
EP1728797A3 (en) 1999-10-13 2011-03-02 Johns Hopkins University School of Medicine Regulators of the hedgehog pathway, compositions and uses related thereto
US6552016B1 (en) 1999-10-14 2003-04-22 Curis, Inc. Mediators of hedgehog signaling pathways, compositions and uses related thereto
EP1227805B2 (en) * 1999-10-14 2011-02-23 Curis, Inc. Mediators of hedgehog signaling pathways, compositions and uses related thereto
AR044510A1 (es) * 2003-04-14 2005-09-14 Merck & Co Inc Procedimiento e intermedios para preparar acidos carboxilicos de pirrolidina
CN114507143A (zh) * 2022-02-26 2022-05-17 江苏壹药新材料有限公司 一种2-乙基-1-氟-4-硝基苯的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2517691A1 (en) * 1994-08-19 1996-02-29 Abbott Laboratories Endothelin antagonists
BR9707394A (pt) * 1996-02-13 1999-04-06 Abbott Lab Derivados de ácido 4-(benzo-1,3-dioxolil) pirrolidino-3-carboxílico como antagonistas endotelina

Also Published As

Publication number Publication date
NO996244L (no) 2000-01-12
BG103986A (en) 2000-08-31
PL348667A1 (en) 2002-06-03
HUP0002681A2 (hu) 2001-08-28
ZA985209B (en) 1999-01-06
NO996244D0 (no) 1999-12-16
AU7826398A (en) 1999-01-04
HUP0002681A3 (en) 2001-09-28
WO1998057933A1 (en) 1998-12-23

Similar Documents

Publication Publication Date Title
AR006309A1 (es) Derivados de pirrolidina, antagonistas de endotelina, composiciones farmaceuticas, uso de dichos derivados para la preparacion de medicamentos y procedimientos para preparar dichos derivados
TW200621768A (en) Aminopiperidine derivatives, preparation thereof and therapeutic use thereof
NO20011479L (no) Nye amidinderivater, fremstilling derav og anvendelse som medikamenter og farmasöytiske sammensetninger inneholdende disse
HUP0001494A2 (hu) 3-Fenoxi-, 3-dibenzo[a,d]cikloheptenil-oxi-, 3-dibenz[b,f]-[1,4]oxazepinil-oxi-1-amino-2-propanol-származékok és az ezeket tartalmazó gyógyszerkészítmények
HUP0302969A2 (hu) NPY Y5 antagonisták, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
AU2003273475A8 (en) N-(phenyl(piperidin-2-yl)methyl)benzamide derivatives, preparation thereof, and use thereof in therapy
SI20744B (sl) Derivati karboksilne kisline, ki inhibirajo vezavo integrinov na njihove receptorje
NZ503262A (en) Hepatitis C NS3 protease inhibitor peptides and peptide analogues
RS20060317A (en) Derivatives of n-/phenyl(alkylpiperidine-2-yl)methyl/ benzamide, preparation method thereof and application of same in therapeutics
AU2888892A (en) 3-ureido-benzodiazepinones useful as antagonists of cck or of gastrine
AR016071A1 (es) Antagonistas de endotelina, composiciones farmaceuticas y uso de dichos compuestos para preparar medicamentos
WO2002062302A3 (en) Steroidal derivatives
EP1000935A4 (en) PYRIDYLACRYLAMIDE DERIVATIVES, NEPHRITIS REMEDIES, AND TGF-BETA INHIBITORS CONTAINING THE SAME
KR970704444A (ko) 트리아진 유도체 및 의약(triazine derivative and medicine)
TR199801210T2 (xx) 1-(1,2-�ift ikameli piperidinil)-4-(kayna�m�� imidazol)piperidin t�revleri.
AR005801A1 (es) Antagonistas de la endotelina, composicion farmaceutica que los contiene y uso de un compuesto antagonista para preparar un medicamento o composicionfarmaceutica
WO2002000638A8 (en) Substituted phthalides as anti-convulsive drugs
EP0375223A3 (en) Novel compounds
DE60130766D1 (de) Serotoninwiederaufnahme-inhibitoren
EP1553096A4 (en) pyrazole
CO5150201A1 (es) Derivados de piperidina
CO5140091A1 (es) Derivados de piperidina y piperazina, su preparacion, su uso como productos farmaceuticos y composiciones farmaceuticas que los contienen
AR015141A1 (es) Derivados heterociclicos antagonistas de endotelina, composicion farmaceutica que los contiene, el uso de los mismos en la manufactura de un medicamento yprocedimiento para su preparacion
CA2278687A1 (en) 5-aroylnaphthalene derivatives
BR0207074A (pt) Emprego de alquilalcoxilatos e arilalcoxilatos como emulsificantes na polimerização de emulsão